A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy
Tomasz M. Beer, Charles Ryan, Joshi Alumkal, Christopher W. Ryan, Janine Sun, Kristine M. Eilers
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy'. Together they form a unique fingerprint.